Vuzix Corp Files 8-K for Material Definitive Agreement
Ticker: VUZI · Form: 8-K · Filed: Sep 8, 2025 · CIK: 1463972
| Field | Detail |
|---|---|
| Company | Vuzix Corp (VUZI) |
| Form Type | 8-K |
| Filed Date | Sep 8, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $360,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, 8-k
Related Tickers: VUZI
TL;DR
VUZI signed a big deal, details TBD.
AI Summary
On September 3, 2025, Vuzix Corporation entered into a material definitive agreement. The filing does not disclose the specific details of this agreement or any associated dollar amounts or parties involved. The report was filed on September 8, 2025.
Why It Matters
This filing indicates a significant new agreement for Vuzix Corporation, which could impact its future business operations and financial performance.
Risk Assessment
Risk Level: medium — The lack of specific details in the filing regarding the material definitive agreement introduces uncertainty about its nature and potential impact.
Key Players & Entities
- Vuzix Corporation (company) — Registrant
- September 3, 2025 (date) — Date of earliest event reported
- September 8, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- New York (state) — Principal executive offices state
FAQ
What is the nature of the material definitive agreement entered into by Vuzix Corporation?
The filing does not specify the nature of the material definitive agreement.
Who are the other parties involved in this material definitive agreement?
The filing does not disclose the names of the other parties involved in the agreement.
Are there any financial terms or dollar amounts associated with this agreement?
The filing does not provide any specific dollar amounts or financial terms related to the agreement.
When was the material definitive agreement entered into?
The material definitive agreement was entered into on September 3, 2025.
What is the purpose of this 8-K filing?
This 8-K filing is to report the entry into a material definitive agreement and to include financial statements and exhibits.
Filing Stats: 555 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2025-09-08 08:15:37
Key Financial Figures
- $0.001 — h registered: Common Stock, par value $0.001 VUZI Nasdaq Capital Market Indica
- $360,000 — n will receive an annual base salary of $360,000 and will participate in the Company's m
Filing Documents
- tm2525426d1_8k.htm (8-K) — 24KB
- tm2525426d1_ex10-1.htm (EX-10.1) — 63KB
- tm2525426d1_ex10-1img002.jpg (GRAPHIC) — 6KB
- 0001104659-25-088065.txt ( ) — 270KB
- vuzi-20250903.xsd (EX-101.SCH) — 3KB
- vuzi-20250903_lab.xml (EX-101.LAB) — 33KB
- vuzi-20250903_pre.xml (EX-101.PRE) — 22KB
- tm2525426d1_8k_htm.xml (XML) — 4KB
01 Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement. On September 3, 2025, Vuzix Corporation (the "Company") entered into an employment offer letter with Chris Parkinson, PhD., the newly appointed president of the Company's Enterprise Solutions business unit. Pursuant to the employment offer letter, Dr. Parkinson will receive an annual base salary of $360,000 and will participate in the Company's management bonus plan and Laddered Long-term Equity Incentive Plan. Mr. Parkinson will also receive 150,000 restricted stock awards ("RSAs"), which will vest in equal portions quarterly over 12 months and 1,000,000 performance stock units ("PSUs"), whose vestisng will be subject to the achievement of certain revenue and EBITDA targets of the Company's Enterprise Solutions business unit by December 31, 2028. In the event Dr. Parkinson is terminated from the Company without cause, he will receive 12 months' severance. In the event there is a Change of Control transaction of the Company, as defined under the Company's 2023 Equity Incentive Plan, Dr. Parkinson's unvested RSAs or PSUs will accelerate as per the terms of those awards...
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 # Offer Letter between the Company and Dr. Chris Parkinson 104 Cover Page Interactive Data File (formatted as Inline XBRL) # Portions of this agreement have been omitted.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 8, 2025 VUZIX CORPORATION By: /s/ Grant Russell Grant Russell Chief Financial Officer